ES2040853T3 - Preparacion de acidos oxoftalazinilaceticos con cadenas laterales de benzotiazol u otros heterociclos. - Google Patents

Preparacion de acidos oxoftalazinilaceticos con cadenas laterales de benzotiazol u otros heterociclos.

Info

Publication number
ES2040853T3
ES2040853T3 ES198888305180T ES88305180T ES2040853T3 ES 2040853 T3 ES2040853 T3 ES 2040853T3 ES 198888305180 T ES198888305180 T ES 198888305180T ES 88305180 T ES88305180 T ES 88305180T ES 2040853 T3 ES2040853 T3 ES 2040853T3
Authority
ES
Spain
Prior art keywords
preparation
side chains
acids
oxoftalazinylacetic
heterocicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888305180T
Other languages
English (en)
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2040853T3 publication Critical patent/ES2040853T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

UN PROCESO PARA LA PREPARACION DE ACIDOS OXOFTALAZINIL ACETICOS CON BENZOTIAZOL U OTRAS CADENAS LATERALES HETEROCICLICAS QUE COMPRENDE LA REACCION DE ESTER DEL ACIDO OXOFTALIZINIL ACETICO CON UN DERIVADO DE ANILINA. TAMBIEN SE PRSENTAN PROCESOS PARA LA PREPARACION DE TALES ESTERES DE OXOFTALIZINILO.
ES198888305180T 1987-06-09 1988-06-07 Preparacion de acidos oxoftalazinilaceticos con cadenas laterales de benzotiazol u otros heterociclos. Expired - Lifetime ES2040853T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5989987A 1987-06-09 1987-06-09

Publications (1)

Publication Number Publication Date
ES2040853T3 true ES2040853T3 (es) 1993-11-01

Family

ID=22026001

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888305180T Expired - Lifetime ES2040853T3 (es) 1987-06-09 1988-06-07 Preparacion de acidos oxoftalazinilaceticos con cadenas laterales de benzotiazol u otros heterociclos.

Country Status (26)

Country Link
EP (1) EP0295051B1 (es)
JP (1) JPH0676391B2 (es)
KR (1) KR900004698B1 (es)
CN (1) CN1024347C (es)
AT (1) ATE90347T1 (es)
AU (1) AU593742B2 (es)
CA (1) CA1321791C (es)
CS (1) CS274628B2 (es)
DD (3) DD280323A5 (es)
DE (1) DE3881583T2 (es)
DK (1) DK309988A (es)
EG (1) EG18613A (es)
ES (1) ES2040853T3 (es)
FI (1) FI93835C (es)
HU (1) HU205108B (es)
IE (1) IE61499B1 (es)
IL (1) IL86660A0 (es)
MY (1) MY103573A (es)
NO (1) NO176317C (es)
NZ (1) NZ224937A (es)
PH (1) PH25928A (es)
PL (1) PL157690B1 (es)
PT (1) PT87669B (es)
SU (1) SU1678208A3 (es)
YU (1) YU46696B (es)
ZA (1) ZA884075B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
US5304557A (en) * 1989-12-15 1994-04-19 Pfizer Inc. Substituted oxoophthalazinyl acetic acids and analogs thereof
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
CA2107104A1 (en) * 1991-03-28 1992-09-29 Banavara L. Mylari Pyridazinone acetic acids as aldose reductase inhibitors
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
DE69405193T2 (de) * 1993-10-06 1998-01-02 Sumika Fine Chemicals Co Ltd Verfahren zur Herstellung von Alkyl-3-phthalidylidenacetat
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
SG82702A1 (en) * 1999-09-28 2001-08-21 Ebauchesfabrik Eta Ag Timepiece including a movement mounted in a casing ring

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) * 1979-06-06 1984-08-02 昭和電工株式会社 ３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.

Also Published As

Publication number Publication date
EP0295051A2 (en) 1988-12-14
HU205108B (en) 1992-03-30
PL272899A1 (en) 1989-07-10
DK309988A (da) 1988-12-10
YU46696B (sh) 1994-04-05
PL157690B1 (en) 1992-06-30
FI882722A0 (fi) 1988-06-08
DK309988D0 (da) 1988-06-08
IE881716L (en) 1988-12-09
FI882722A (fi) 1988-12-10
JPH0676391B2 (ja) 1994-09-28
AU1749188A (en) 1988-12-15
AU593742B2 (en) 1990-02-15
FI93835C (fi) 1995-06-12
DD280323A5 (de) 1990-07-04
SU1678208A3 (ru) 1991-09-15
PT87669B (pt) 1992-09-30
FI93835B (fi) 1995-02-28
EP0295051B1 (en) 1993-06-09
NO176317C (no) 1995-03-15
DD280320A5 (de) 1990-07-04
NO882516D0 (no) 1988-06-08
CN1024347C (zh) 1994-04-27
DD281600A5 (de) 1990-08-15
YU111188A (en) 1989-12-31
ATE90347T1 (de) 1993-06-15
ZA884075B (en) 1990-02-28
DE3881583D1 (de) 1993-07-15
IE61499B1 (en) 1994-11-02
PT87669A (pt) 1988-07-01
EP0295051A3 (en) 1989-03-22
KR890000476A (ko) 1989-03-14
NO176317B (no) 1994-12-05
MY103573A (en) 1993-08-28
CN88103507A (zh) 1988-12-28
PH25928A (en) 1991-12-19
NO882516L (no) 1988-12-12
JPS643173A (en) 1989-01-06
CS274628B2 (en) 1991-09-15
DE3881583T2 (de) 1993-09-16
CS392488A2 (en) 1990-08-14
CA1321791C (en) 1993-08-31
NZ224937A (en) 1991-01-29
EG18613A (en) 1993-08-30
IL86660A0 (en) 1988-11-30
KR900004698B1 (ko) 1990-07-02

Similar Documents

Publication Publication Date Title
ES2040853T3 (es) Preparacion de acidos oxoftalazinilaceticos con cadenas laterales de benzotiazol u otros heterociclos.
BR8207492A (pt) Processo para a coproducao de acidos carboxilicos de formula geral r1 - c00h e r2 - c00h e esteres de acidos carboxilico de formula geral r1 - c00chr2 e r2 - c00ch2r1
ES2052511T3 (es) Acidos 4-halogeno-2-oxiimino-3-oxobutiricos.
ZA868121B (en) Process for the enzymatic separation of the optical isomers of 2-aminobutanol
AU605754B2 (en) Process for acylating amines with 2-benzothiazolyl thioesters of carboxylic acids
DE3855070D1 (de) Herstellungsverfahren von Propionsäureestern
ZA885968B (en) A process for the enzymatic preparation of optically active phosphorus-containing functional acetic acid derivatives
ATE33821T1 (de) Verfahren zur herstellung von halogenierten 3,3- dimethyl-5-hexen-2-onen.
EP0397048A3 (de) Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester
NO890815D0 (no) Fremgangsmaate for fremstilling av ftalazineddiksyreester-derivater.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 295051

Country of ref document: ES